Cancers, Vol. 15, Pages 148: Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer

Figure 1. Expected benefit by improving workflow and streamline processes.

Cancers 15 00148 g001

Table 1. Example of how the integration of RS Clin can refine the indication for adjuvant treatment, especially for intermediate to high RS value.

Table 1. Example of how the integration of RS Clin can refine the indication for adjuvant treatment, especially for intermediate to high RS value.

Patient of 40 yo, N0, 1 cm, Grade 1 RS 24RS 27Delta CTRS alone9y DR ET10%16% CT benefit<1%>15%15%RS + CP (low)9y DR ET11.5%16% CT benefit6.5%>15%8.5%RS Clin10y DR TAM7%7% CT benefit3%4%1%

Comments (0)

No login
gif